NCI director to step down; research on mice that ‘sweat out’ fat wins STAT Madness

Ned Sharpless, who spent nearly five years leading the National Cancer Institute within the NIH, will step down at the end of April. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

NIH's cancer chief, Ned Sharpless, to step down By Lev Facher DOULIERY/AFP via Getty Images Sharpless, who spent nearly five years leading the National Cancer Institute within the NIH, will step down at the end of April, he told STAT. Read More Listen: How one 1910 report curtailed Black medical education for over a century By Nicholas St. Fleur Keisha Okafor for STAT Medicine in America underwent a radical transformation in 1910 that led to the closure of all but two medical schools open to Black students. Read More STAT+: The biotech scorecard for the second quarter: 21 stock-moving events to watch By Adam Feuerstein Ryan Pierse/Getty Images There's plenty to watch out for in the months ahead, including a readout from Alnylam Pharmaceuticals and another from Roche. Read More Sponsor content by STAT Events Battle scars: The journey from lab to patient's bedside Join STAT on May 3 in Boston to explore the challenges, and the unique opportunities for new approaches, solutions, and partnerships, of the drug development process. This in-person program will bring together a diverse group of individuals to share their perspectives about the drug development process. Stay once the conversation is complete for a networking and cocktail reception with STAT and your fellow attendees. Get your ticket now (and save 40% as a STAT+ subscriber). Research on mice that 'sweat out' fat wins STAT Madness for University of Pennsylvania By Maddie Bender Hechler Photographers for STAT The research that emerged victorious arose from a "serendipitous" finding in an experiment on type 2 diabetes. Read More Opinion: Equal treatment for equal risk: Should race be included in allocation algorithms for Covid-19 therapies? By David M. Kent and Keren Ladin and O. Kenrik Duru Adobe Disparaging all race-aware risk prediction models is misleading when including race can sometimes improve both health outcomes and fairness. Read More STAT+: Medicare Part D and its beneficiaries could have saved millions if more biosimilars were accessible By Ed Silverman Adobe A new government analysis found that broader biosimilar use could have cut Medicare Part D spending on biologic medicines significantly. Read More Monday, April 4, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser